Scandion Oncology A/S (SCOL.ST)

SEK 0.08

(-6.78%)

Total Debt Summary of Scandion Oncology A/S

  • Scandion Oncology A/S's latest annual total debt in 2023 was 499 Thousand DKK , down -68.75% from previous year.
  • Scandion Oncology A/S's latest quarterly total debt in 2024 Q2 was 180 Thousand DKK , down -33.09% from previous quarter.
  • Scandion Oncology A/S reported annual total debt of 1.59 Million DKK in 2022, up 30.58% from previous year.
  • Scandion Oncology A/S reported annual total debt of 1.22 Million DKK in 2021, up 287.03% from previous year.
  • Scandion Oncology A/S reported quarterly total debt of 269 Thousand DKK for 2024 Q1, down -46.09% from previous quarter.
  • Scandion Oncology A/S reported quarterly total debt of 1.2 Million DKK for 2023 Q2, down -13.98% from previous quarter.

Annual Total Debt Chart of Scandion Oncology A/S (2023 - 2017)

Historical Annual Total Debt of Scandion Oncology A/S (2023 - 2017)

Year Total Debt Total Debt Growth
2023 499 Thousand DKK -68.75%
2022 1.59 Million DKK 30.58%
2021 1.22 Million DKK 287.03%
2020 316 Thousand DKK 22122.22%
2019 1422.00 DKK 0.0%
2018 - DKK 0.0%
2017 - DKK 0.0%

Peer Total Debt Comparison of Scandion Oncology A/S

Name Total Debt Total Debt Difference
Lipum AB (publ) 1.76 Million SEK 71.664%
Alligator Bioscience AB (publ) 16.09 Million SEK 96.9%
Modus Therapeutics Holding AB (publ) - SEK -Infinity%
BioArctic AB (publ) 4.97 Million SEK 89.978%
Sprint Bioscience AB (publ) - SEK -Infinity%
Mendus AB (publ) 24.48 Million SEK 97.962%
Intervacc AB (publ) 181 Thousand SEK -175.691%
QuiaPEG Pharmaceuticals Holding AB (publ) 20.61 Million SEK 97.579%
Active Biotech AB (publ) 3 Million SEK 83.367%
Magle Chemoswed Holding AB (publ) 60.3 Million SEK 99.172%
Bio-Works Technologies AB (publ) - SEK -Infinity%
Aptahem AB (publ) 5 Million SEK 90.02%
Vicore Pharma Holding AB (publ) - SEK -Infinity%
Kancera AB (publ) - SEK -Infinity%
Infant Bacterial Therapeutics AB (publ) - SEK -Infinity%
Fluicell AB (publ) - SEK -Infinity%
Saniona AB (publ) 71.4 Million SEK 99.301%
Lipigon Pharmaceuticals AB (publ) - SEK -Infinity%
Biovica International AB (publ) 7.82 Million SEK 93.625%
Spago Nanomedical AB (publ) - SEK -Infinity%
AcouSort AB (publ) - SEK -Infinity%
Xintela AB (publ) - SEK -Infinity%
Ziccum AB (publ) 857 Thousand SEK 41.774%
Genovis AB (publ.) 79.32 Million SEK 99.371%
Abliva AB (publ) 424 Thousand SEK -17.689%
Egetis Therapeutics AB (publ) 108.6 Million SEK 99.541%
Karolinska Development AB (publ) 3.07 Million SEK 83.746%
OncoZenge AB (publ) - SEK -Infinity%
CombiGene AB (publ) - SEK -Infinity%
Camurus AB (publ) 24.5 Million SEK 97.964%
Corline Biomedical AB - SEK -Infinity%
Amniotics AB (publ) 2.58 Million SEK 80.659%
IRLAB Therapeutics AB (publ) 27.56 Million SEK 98.19%
2cureX AB (publ) - SEK -Infinity%
Asarina Pharma AB (publ) 1 Million SEK 50.1%
Calliditas Therapeutics AB (publ) 979.13 Million SEK 99.949%
Xspray Pharma AB (publ) 36.8 Million SEK 98.644%
Elicera Therapeutics AB (publ) - SEK -Infinity%
Isofol Medical AB (publ) - SEK -Infinity%
Stayble Therapeutics AB (publ) 850 Thousand SEK 41.294%
I-Tech AB - SEK -Infinity%
Hansa Biopharma AB (publ) 866.76 Million SEK 99.942%
Cyxone AB (publ) 858 Thousand SEK 41.841%
ExpreS2ion Biotech Holding AB (publ) 1.71 Million SEK 70.836%
Biosergen AB - SEK -Infinity%
Cantargia AB (publ) - SEK -Infinity%
NextCell Pharma AB - SEK -Infinity%
Nanologica AB (publ) 666 Thousand SEK 25.075%
SynAct Pharma AB 637 Thousand SEK 21.664%
Annexin Pharmaceuticals AB (publ) - SEK -Infinity%
LIDDS AB (publ) - SEK -Infinity%
BioInvent International AB (publ) 23.24 Million SEK 97.853%
Alzinova AB (publ) 800 Thousand SEK 37.625%
Oncopeptides AB (publ) 106.48 Million SEK 99.531%
Guard Therapeutics International AB (publ) - SEK -Infinity%
Pila Pharma AB (publ) 773.08 Thousand SEK 35.453%
Scandinavian ChemoTech AB (publ) - SEK -Infinity%
Simris Alg AB (publ) 90.74 Million SEK 99.45%
Diamyd Medical AB (publ) 30.67 Million SEK 98.373%
Xbrane Biopharma AB (publ) 231.47 Million SEK 99.784%
Ascelia Pharma AB (publ) 1.06 Million SEK 52.969%
Diagonal Bio AB (publ) - SEK -Infinity%